Skip to content

Clinical trials

Epilepsies, Myoclonic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20162
20171
20192
20211
20223
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Assistance Publique - Hôpitaux de Paris2
Hospices Civils de Lyon2
Longboard Pharmaceuticals2
Takeda2
Biocodex1
Centre Hospitalier Universitaire, Amiens1
Fondation Ophtalmologique Adolphe de Rothschild1
Jazz Pharmaceuticals1
Loulou Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic18
Epilepsy11
Seizures5
Brain Diseases3
Lennox Gastaut Syndrome3
Neurodevelopmental Disorders2
Drug Resistant Epilepsy1
Epileptic Syndromes1
Learning Disabilities1
Spasms, Infantile1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.